title: Peripheral blood progenitor cell collection during hematopoietic recovery following autologous blood progenitor cell transplantation.
abstract: OBJECTIVE
  Peripheral blood progenitor cells (PBPC) are increasingly used for autologous transplantation after high-dose radio/chemotherapy in patients suffering from cancer. PBPC are usually collected after mobilization with conventional-dose chemotherapy plus growth factor. However, it is conceivable to perform leukapheresis for the second autograft during recovery of hematopoiesis after the first course of HDCT/ABPCT.
  
  
  METHODS
  We treated two patients this way. In the first, with germ cell cancer, six 12-liter leukaphereses yielded 1.8 x 10(6) CD34+ cells/kg after mobilization with cis-platinum, etoposide and ifosfamide (PEI) plus granulocyte colony-stimulating factor (G-CSF). The second patient, with relapsed Hodgkin's disease, underwent PBPC collection after treatment with dexamethasone, carmustine, etoposide, cytarabine and melphalan (DexaBEAM) plus G-CSF. Due to excellent mobilization, 8.5 x 10(6) CD34+ cells/kg were collected by one 12-liter leukapheresis. Both patients then underwent PBPC collection during hematopoietic recovery following HDCT and ABPCT.
  
  
  RESULTS
  In patient 1, following HDCT and ABPCT, three 12-liter aphereses resulted in 0.7 x 10(6) CD34+ cells/kg. In patient 2, also after HDCT and ABPCT, a second autograft with 3.2 x 10(6) CD34+ cells/kg was harvested by a single 10-liter apheresis. No adverse effects were seen in either patient during apheresis following ABPCT. To our knowledge this is the first report dealing with PBCT collection during hematopoietic recovery following HDCT and ABPCT.
  
  
  CONCLUSIONS
  (1) PBPC harvesting is feasible and well tolerated in this setting. (2) In appropriate patients with efficient PBPC mobilization after conventional-dose chemotherapy, a further PBPC autograft can be collected during recovery of hematopoiesis after ABPCT, serving as a rescue for a second course of HDCT.
authors.affiliation: Department of Internal Medicine, Humboldt University, Berlin, Germany.
authors.forename: N
authors.initials: N
authors.lastname: Schwella
authors.forename: D
authors.initials: D
authors.lastname: Kingreen
authors.forename: H G
authors.initials: HG
authors.lastname: Heuft
authors.forename: H
authors.initials: H
authors.lastname: Oettle
authors.forename: O
authors.initials: O
authors.lastname: Rick
authors.forename: S
authors.initials: S
authors.lastname: Serke
authors.forename: D
authors.initials: D
authors.lastname: Huhn
authors.forename: W
authors.initials: W
authors.lastname: Siegert
mesh_terms: D000328:Adult; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D006801:Humans; D007937:Leukapheresis; D008297:Male; D014182:Transplantation, Autologous